Zobrazeno 1 - 8
of 8
pro vyhledávání: '"R L, McLeod"'
Autor:
Jonathan Banting, R L McLeod, T Ho, Vijayaragavan Muralidharan, V Liang, Damian Ianno, K Fernandes, Leonid Churilov, Laurence Weinberg, Christopher Christophi, I Chao, Mehrdad Nikfarjam
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
In this retrospective observational study performed in a high-volume hepatobiliary–pancreatic unit, we evaluated the effect of a surgery-specific goal-directed therapy (GDT) physiologic algorithm on complications and length of hospital stay. We com
Publikováno v:
American journal of rhinology. 15(6)
The effect of alpha2-selective adrenoreceptor activation on nasal cavity dimension in an experimental model of congestion has not been defined. Presently, we used acoustic rhinometry to evaluate the decongestant activity of BHT-920, a selective alpha
Autor:
R L, McLeod, L E, Parra, J C, Mutter, C H, Erickson, G J, Carey, D B, Tulshian, A B, Fawzi, A, Smith-Torhan, R W, Egan, F M, Cuss, J A, Hey
Publikováno v:
British journal of pharmacology. 132(6)
We studied the central and peripheral antitussive effect of ORL(1) receptor activation with nociceptin/orphanin FQ in conscious guinea-pigs. In guinea-pig cough studies, nociceptin/orphanin FQ (10, 30, and 90 microg) given directly into the CNS by an
Autor:
J A, Hey, R, Aslanian, D C, Bolser, R W, Chapman, R W, Egan, C A, Rizzo, N Y, Shih, X, Fernandez, R L, McLeod, R, West, W, Kreutner
Publikováno v:
Arzneimittel-Forschung. 48(9)
Experiments were performed to characterize the pharmacology of Sch 50971 ((+)-trans-4-(4(R)-methyl-3(R)-pyrolidinyl)-1H-imidazole dihydrochloride, CAS 167610-28-8), a novel histamine H3 receptor agonist. The activity of Sch 50971 was compared with th
Autor:
R L, McLeod, R, Aslanian, M, del Prado, R, Duffy, R W, Egan, W, Kreutner, R, McQuade, J A, Hey
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 287(1)
We studied the actions of Sch 50971, a novel histamine H3 receptor agonist, in an experimental neurogenic model of migraine and characterized its sedative and respiratory actions. Sch 50971 (i.v. and p.o) inhibited plasma protein extravasation in the
Autor:
M, Van Heek, C F, France, D S, Compton, R L, McLeod, N P, Yumibe, K B, Alton, E J, Sybertz, H R, Davis
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 283(1)
SCH48461 is a selective and highly potent inhibitor of cholesterol absorption. In rats, SCH48461 is rapidly and completely metabolized in the first pass through the body. To compare the activity of the metabolites of SCH48461 with SCH48461 itself, an
Autor:
R. L. McLeod, R. L. Stanton
Publikováno v:
Economic Geology. 79:1-22
The Pb-Zn ores of eight of the nine deposits are characterized by one or the other of the phyllosilicate assemblages chlorite + talc + phlogopite-biotite or chlorite + muscovite. The other contains chlorite + phlogopitic trioctahedral mica but no tal
Autor:
R. L. McLeod
Publikováno v:
TMPM Tschermaks Mineralogische und Petrographische Mitteilungen. 34:261-269
The Permian Mount Chalmers copper-gold deposit in Central Queensland, Australia, has a mineralogy, form, and setting similar to the kuroko deposits of Japan. Clay observed in the Mount Chalmers deposit is considered to have formed by subsea-floor rep